Of note is the robust colocalization unveiled between CTSH expression within TH2 cells and the propensity for MG risk, signifying a putative involvement of CTSH expression within this cellular subtype in driving the genesis and advancement of MG. The gene discussed is CTSH; the disease is myasthenia gravis.